fig1
Figure 1. Schematic of the lncRNAs that contribute to therapeutic resistance in a variety of malignancies. The arrows represents the direction of dysregulation when cancer is in a therapeutic resistant state
Figure 1. Schematic of the lncRNAs that contribute to therapeutic resistance in a variety of malignancies. The arrows represents the direction of dysregulation when cancer is in a therapeutic resistant state
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/